You are here

Home » Content

Guillain-Barre: Klinik ve Prognostik Özellikler

Guillain-Barre: Clinical And Prognostic Features

Journal Name:

  • Fırat Tıp Dergisi

Publication Year:

  • 2004

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Objective: Assessment of Guillain-Barre syndrome (GBS) cases in Dr. Lütfi Kirdar Kartal Education and Research Hospital over a 2-year period; investigation of a relationship between possible seasonality in GBS and the occurrence of preceding infections; and determination of distinctive characteristics and treatment protocols in patients with GBS. Materials and method: Records of patients with GBS admitted between 2001 and 2003 were evaluated retrospectively and prospectively Results: A total of 14 patients had a diagnosis of GBS. Patients above 50 years of age and men were more frequently found in the severely affected group. Men were more frequently affected than women. A preceding infection was reported in 78.5% of the cases. There was not any significance between therapy protocols and prognosis. Conclusion: The clinical and prognostic features of present study were the similar in previous reports. The severity increases with age and men are more frequently affected than women. The therapy protocols did not affect the prognosis in GBS. ©2004, Fırat Üniversitesi, Tıp Fakültesi
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: İki yılın üstü bir süreçte Dr.Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi'ndeki GBS vakalarının değerlendirilmesi; GBS ile mevsimler ve öncesinde görülebilecek ilişkilerin değerlendirilmesi; GBS hastalarında ayırt edici özelliklerin ve tedavi protokollerinin belirlenmesi. Gereç ve yöntem: 2001 ve 2003 yılları arasında yatarak takipleri yapılmış hastaların kayıtları geriye ve ileriye dönük olarak değerlendirildi. Sonuç: Toplam 14 hasta GBS tanısı aldı. Elli yaş üstü ve erkek vakalarda hastalık daha ağır seyretmekteydi. Erkekler kadınlardan daha sıklıkla hastalığa maruz kalmaktaydı. GBS öncesi enfeksiyon olguların %78,5'inde rapor edildi. Tedavi protokolleri ve prognoz arasında istatistiksel bir ilişki yoktu. Bu çalışmadaki klinik ve prognostik veriler daha önce literatürde rapor edilenlere benzerdi. Hastalığın şiddeti yaş ile artmaktaydı ve erkekler hastalığa kadınlardan daha fazla maruz kalmaktaydı. Tedavi protokolleri GBS hastalarında prognozu etkilemedi. ©2004, Fırat Üniversitesi, Tıp Fakültesi
FULL TEXT (PDF): 
PDF icon arastirmax-guillain-barre-klinik-prognostik-ozellikler.pdf
  • 4
108-111
  • Turkish

REFERENCES

References: 

1. Hughes RAC, Rees JH. Clinical and epidemiological features of Guillian-Barre syndrome. J Infections Dis 1997 ; l76 : 92-98
2. Beghi E, Kurland LT, Molder DW, Wiederholt WC. Guillian-Barre syndrome: clinico-epidemiologic features and effect at influenza vaccine. Arch Neural 996; 42:53-57.
3. Govoni V, Granieri E, Casetta I, et al. The incidence of Guillian-Barre syndrome in Ferrara, Italy: is the disease really increasing? J Neurol Sci 1996; 137:62-68.
4. Halls J, Bredkjaer C, Friis ML. Guillain-Barre syndrome: di¬agnostic criteria, epidemiology, clinical course and prognosis. Acta Neurol Scand 1988; 78:118-122.
5. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990; 27: 21-24.
6. Koningsveld RV, Van DSoorn PA, Schmitz PIM, et al. Mild forms of Guillain-Barre syndrome in an epidemiologic survey in the
Netherlands. Neurology 2000; 54: 620-625.
7. Ropper AH. The Guillain-Barre syndrome. N Engl J Med 1992;
23:1130-1136.
8. Roman GC. Tropical neuropathies. In: Hartung H-P, ed. Peripheral neuropathies: part I. London: Bailliere Tindall 1995; 469—487.
9. Jiang GX, de Pedro-Cuesta J, Fredrikson S. Guillain-Barre Syndrome in southwest Stockholm, 1973-1991, 1. Quality of registered hospital diagnoses and incidence. Acta Neurol Scand
1995; 91:109-117.
10. Larsen JP, Kvale G, Nyland H. Epidemiology of the Guillain-Barre Syndrome in the county of Hordaland, western Norway. Acta Neurol Scand 1985; 71:43-47.
11. Winner SJ, Evans JG. Age-specific incidence of Guillain-Barre syndrome in Oxfordshire. Q J Med l990; 77:1297-1304.
12. Rees JH, Thompson RD, Hughes RAC. An epidemiological study of Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1996; 61:215.
13. Khoury SA. Guillain-Barre syndrome: epidemiologic of an
outbreak. Am J Epidemiol 1978; l97:433-438.
14. Rees JH, Soudain SE, Gregson NA, Hughes RAC. A prospective case control study to investigate the relationship between Campylobacter jejune infection and Guillain-Barre syndrome. N Engl J Med 1995:333:1374-1379.
15. Ho TW, Mishu
B
, Li CY, et al. Guillain-Barre syndrome in northern China. Relationship to Campylobacter Jejuni infection and anti-glycolipid antibodies. Brain 1995; 118: 597-605.
16. Aspinall GO, Fujimoto S, Mc Donald AG, et al.
Lipopolysaccharides Campylobacter Jejuni associated with Guillain-Barre syndrome patients mimic human gangliosides in
structure. Infect Immun 1994; 62:2122-2125.
17. Hadden RDM, Cornblath DR, Hughes RAC, et al.
Electrophysiological classification of Guillain-Barre syndrome; clinical associations and outcome. Ann Neurol 1998;44; 780-788
18. Begin E, Kurland LT, Mulder DW, Wiederholt WC. Guillain-
Barre syndrome. Clinico-epidemiologic features and effect of
influenza vaccine. Arch Neurol 1985; 42:1053-1057.
19. Kaplan JE, Schonherger LB, Hurwitz ES, Katona P. Guillain-Barre syndrome in the United States 1978-81; additional observations from the national surveillance system. Neurology
1983:33:633-637.
20. Sedano MJ, Calleja J, Canga E, Berciano J. Guillain-Barre Syndrome in Cantabria, Spain. An epidemiologic and clinical
study. Acta Nerol Scand 1994; 89:287-292.
21. Rees JH, Thompson RD, Smeeton NC, Hughes RAC. An
epidemiological study of Guillain-Barre syndrome in southeast England. J Neurol Neurosurg Psychiatry 1998; 64:74-77.
22. Emilia-Romagna Study Group on Clinical and Epidemiologic Problems in Neurology. A prospective study on the incidence and diagnosis of Guillain-Barre syndrome in Emilia-Romagna region,
Italy (1992-1993). Neurology 1997; 48:214-221.
23. Koobatian Td, Birkhead GS, Schramm MM, Vogt RL. The use of hospital data for public health surveillance of Guillain-Barre Syndrome. Ann Neurol 1991; 30:618-621.
24. Bak P. Guillain-Barre syndrome in a Danish county. Neurology
1985; 35:207-211.
110
Fırat Tıp Dergisi 2004;9(4):108-111
Koçer
25. Winer JB, Hughes RAC, Osmond C. A prospective study of acute idiopathic neuropathy. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry 1988:51:605-12.
26. Mc Khann GM, Griffin JW, Cornblath DR, et al. Plasmapheresis
and Guillain-Barre syndrome: analysis of prognostic factors and the effect of plasmapheresis. Ann Neurol l988; 23:347-353.
27. Van der Meche FGA, Schmitz FIM. Dutch Guillain-Barre Study
Group. A randomized trial of comparing IV immunoglobulin and plasma exchange in Guillain-Barre syndrome. N Engl J Med 1992;
326:1123-1129.
28. The Dutch Guillain-Barre Study Group. Treatment of Guillain-Barre syndrome with high-dose immunoglobulin combined with methylprednisolone: a pilot study. Ann Neurol 1994; 35:749-752.
29. Plasma Exchange/Sandoglobulin Guillain-Barre Syndrome Trial Group. Randomized trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barre
syndrome. Lancet 1997; 349: 225-230.

Thank you for copying data from http://www.arastirmax.com